Clinical Trials for BAY 43-9006 (Sorafenib)

3 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
TreatmentCOGAAML1031
08/24/2011
AAML1031 - A Phase III Randomized Trial for Patients with de novo AML using Bortezomib (IND# 58443, NSC# 681239) and Sorafenib (BAY 43-9006, IND# 69896, NSC# 724772) for Patients with High Allelic Ratio FLT3/ITD
TreatmentVICCRAD1060
02/15/2011
A Phase I Trial of Sorafenib and Stereotactic Radiosurgery for Patients with 1-4 Brain Metastases
TreatmentCTSUGIC80802-M
12/07/2010
Phase III randomized study of sorafenib (IND 69896, NSC 724772) plus doxorubicin versus sorafenib in patients with advanced hepatocellular carcinoma (HCC)

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.